Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

The goal of this clinical trial is to learn whether the addition of spinal analgesia leads to superior recovery in patients undergoing robotic-assisted laparoscopic upper urinary tract surgery under general anesthesia. The main questions it aims to answer are: * Is the decrease in wellbeing as quantified by the patient-centered outcome scale "Quality of Recovery 15" (QoR-15), from baseline to the first day after surgery (POD 1), at least 8.0 points less in patients receiving spinal analgesia in addition to general anesthesia? * Does spinal analgesia result in improved recovery as quantified b

Trial Details

NCT ID
NCT06349668
Phase
PHASE3
Sponsor
Hans Bahlmann
Status
RECRUITING
Cancer Type
Kidney Cancer
Interventions
  • spinal analgesia with morphine and bupivacaine
  • lidocaine infusion
Locations (sample)
  • Kalmar, Sweden|56.66157,16.36163
  • Linköping, Sweden|58.41086,15.62157
  • Vaxjo, Sweden|56.87767,14.80906

Key Eligibility Criteria

  • The patient is scheduled for elective robotic-assisted upper urinary tract surgery at one of the participating hospitals
  • The patient gives oral and written informed consent after having received oral and writen information about the study

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Kidney Cancer Trials on Trialify →